Saturday 17 October 2026
Export CUPR’s income statement to Excel — free account
Cuprina Holdings (Cayman) Limited
CUPR Healthcare Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited’s revenue for fiscal 2025 (year ended December 2025) was $38,800.00, up 9.30% from fiscal 2024.
1.90
0.05
−2.56%
Follow CUPR
| Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|
Current Ratio |
0.27 | 3.58 | 2.35 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 |
Debt/Assets |
12.55% | 1.77% | 4.38% |
Debt/Equity |
(0.05) | 0.03 | 0.07 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(0.52) | (0.29) | (1.60) |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 |
Free Cash Flow |
(0.93) | (6.46) | (7.15) |
Working Capital |
(3.22) | 6.08 | 3.28 |
Capital Expenditures |
(0.02) | 0.00 | (0.05) |
Net Current Asset Value |
(3.34) | 5.97 | 3.02 |
| Other line items | |||
Quick Ratio |
0.04 | 1.44 | 1.08 |
Operating CF per Share |
0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Columns are period end dates